Malignant melanomas on head/neck and foot: Differences in time and latitudinal trends in Norway

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 7, 2012, Pages 821-827

  Juzeniene, A ^a   Micu, E ^a   Porojnicu, A C ^a   Moan, J ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CUTANEOUS MALIGNANT MELANOMA; FEMALE; FOOT CUTANEOUS MALIGNANT MELANOMA; HEAD AND NECK CANCER; HEAD AND NECK CANCER CUTANEOUS MALIGNANT MELANOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NORWAY; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN CARCINOGENESIS; ULTRAVIOLET RADIATION;

FEMALE; FOOT; HEAD; HUMANS; INCIDENCE; MALE; MELANOMA; NECK; NORWAY; REGISTRIES; SKIN NEOPLASMS;

EID: 84862771938     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04162.x     Document Type: Article

References (71)

1. Garibyan L, Fisher DE,. How sunlight causes melanoma. Curr Oncol Rep 2010; 12: 319-326.
2. Seo SJ, Fisher DE,. Melanocyte photobiology, ultraviolet radiation and melanoma. G Ital Dermatol Venereol 2010; 145: 603-611.
3. Tang MS,. Ultraviolet a light: potential underlying causes of melanoma. Future Oncol 2010; 6: 1523-1526.
4. MacKie RM, Hauschild A, Eggermont AM,. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009; 20 (Suppl 6): vi1-vi7.
5. Porojnicu AC, Lagunova Z, Robsahm TE, et al. Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat 2007; 102: 323-328. (Pubitemid 46474836)
6. Moan J, Porojnicu A, Lagunova Z, et al. Colon cancer: prognosis for different latitudes, age groups and seasons in Norway. J Photochem Photobiol B 2007; 89: 148-155. (Pubitemid 350167124)
7. Moan J, Porojnicu AC, Dahlback A,. Ultraviolet radiation and malignant melanoma. Adv Exp Med Biol 2008; 624: 104-116.
8. Cross A, Collard M, Nelson A,. Body segment differences in surface area, skin temperature and 3D displacement and the estimation of heat balance during locomotion in hominins. PLoS ONE 2008; 3: e2464.
9. Setlow RB,. Spectral regions contributing to melanoma: a personal view. J Investig Dermatol Symp Proc 1999; 4: 46-49. (Pubitemid 29491254)
10. Moan J, Dahlback A, Setlow RB,. Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem Photobiol 1999; 70: 243-247. (Pubitemid 129549215)
11. De Fabo EC,. Initial studies on an in vivo action spectrum for melanoma induction. Prog Biophys Mol Biol 2006; 92: 97-104. (Pubitemid 43831952)
12. Walker G,. Cutaneous melanoma: how does ultraviolet light contribute to melanocyte transformation? Future Oncol 2008; 4: 841-856.
13. Di Lucca J, Guedj M, Descamps V, et al. Interactions between ultraviolet light exposure and DNA repair gene polymorphisms may increase melanoma risk. Br J Dermatol 2010; 162: 891-893.
14. Elwood JM, Gallagher RP, Hill GB, et al. Cutaneous melanoma in relation to intermittent and constant sun exposure-the Western Canada Melanoma Study. Int J Cancer 1985; 35: 427-433. (Pubitemid 15047226)
15. Moan J, Dahlback A,. The relationship between skin cancers, solar radiation and ozone depletion. Br J Cancer 1992; 65: 916-921.
16. Newton-Bishop JA, Chang YM, Elliott F, et al. Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur J Cancer 2011; 47: 732-741.
17. Stang A, Lampert T, Uhlemann T, et al. Skin cancer mortality in Germany before and after the post-communist transition. Int J Dermatol 2009; 48: 363-370.
18. Levell NJ, Beattie CC, Shuster S, et al. Melanoma epidemic: a midsummer night's dream? Br J Dermatol 2009; 161: 630-634.
19. Helsing P, Faye R, Langmark F,. Cutaneous malignant melanoma. Correlation between tumor characteristics and diagnostic delay in Norwegian patients. Eur J Dermatol 1997; 7: 359-361. (Pubitemid 27316142)
20. Faye RS, Helsing P, Langmark F,. [Diagnostic delay in malignant melanoma]. Tidsskr Nor Laegeforen 2000; 120: 1023-1025.
21. Weinstock MA,. Ultraviolet radiation and skin cancer: epidemiological data from the United States and Canada. In, Young AR, Young A, Bjorn LO, et al., eds. Environmental UV Photobiology. Plenum Press, New York, 1993: 295-344.
22. Moan J, Porojnicu AC, Dahlback A, et al. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci USA 2008; 105: 668-673. (Pubitemid 351171766)
23. Gaudette LA, Gao RN,. Changing trends in melanoma incidence and mortality. Health Rep 1998; 10: 29-41.
24. Lens MB, Dawes M,. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004; 150: 179-185. (Pubitemid 38352453)
25. Benjamin CL, Melnikova VO, Ananthaswamy HN,. Models and mechanisms in malignant melanoma. Mol Carcinog 2007; 46: 671-678. (Pubitemid 47255186)
26. Cicarma E, Juzeniene A, Porojnicu AC, et al. Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007. J Photochem Photobiol B 2010; 101: 174-178.
27. Porojnicu AC, Dahlback A, Moan J,. Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv Exp Med Biol 2008; 624: 43-54.
28. Holick MF,. Evolution and function of vitamin D. Recent Results Cancer Res 2003; 164: 3-28.
29. Moan J, Cicarma E, Setlow R, et al. Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation. Dermatoendocrinol 2010; 2: 3-8.
30. Moan J, Porojnicu AC, Dahlback A, et al. Where the sun does not shine: is sunshine protective against melanoma of the vulva? J Photochem Photobiol B 2010; 101: 179-183.
31. Egan KM,. Vitamin D and melanoma. Ann Epidemiol 2009; 19: 455-461.
32. Field S, Newton-Bishop JA,. Melanoma and vitamin D. Mol Oncol 2011; 25: 197-214.
33. Holvik K, Meyer HE, Sogaard AJ, et al. Pakistanis living in Oslo have lower serum 1,25-dihydroxyvitamin D levels but higher serum ionized calcium levels compared with ethnic Norwegians. The Oslo Health Study. BMC Endocr Disord 2007; 7: 9.
34. Lagunova Z, Porojnicu AC, Lindberg F, et al. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009; 29: 3713-3720.
35. Christensen MH, Lien EA, Hustad S, et al. Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. Scand J Clin Lab Invest 2010; 70: 281-286.
36. Brustad M, Alsaker E, Engelsen O, et al. Vitamin D status of middle-aged women at 65-71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 2004; 7: 327-335. (Pubitemid 38419619)
37. Lasithiotakis KG, Leiter U, Gorkievicz R, et al. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer 2006; 107: 1331-1339. (Pubitemid 44452783)
38. Moan J, Dahlback A,. Ultraviolet radiation and skin cancer: epidemiological data from Scandinavia. In, Young AR, Young A, Bjorn LO, et al., eds. Environmental UV Photobiology. Plenum Press, New York, 1993: 255-93.
39. Autier P, Dore JF, Gefeller O, et al. Melanoma risk and residence in sunny areas. EORTC Melanoma Co-operative Group. European Organization for Research and Treatment of Cancer. Br J Cancer 1997; 76: 1521-1524.
40. Grant WB,. Solar ultraviolet irradiance and cancer incidence and mortality. Adv Exp Med Biol 2008; 624: 16-30.
41. Gorham ED, Mohr SB, Garland CF, et al. Do sunscreens increase risk of melanoma in populations residing at higher latitudes? Ann Epidemiol 2007; 17: 956-963. (Pubitemid 350101231)
42. Moan J,. Visible Light and UV Radiation. In, Brune D, Hellborg R, Persson BRR, et al., eds. Radiation at Home, Outdoors and in the Workplace. Scandinavian Science Publisher, Oslo, 2001: 69-85.
43. Garland FC, White MR, Garland CF, et al. Occupational sunlight exposure and melanoma in the U.S. Navy. Arch Environ Health 1990; 45: 261-267.
44. Holman CD, Mulroney CD, Armstrong BK,. Epidemiology of pre-invasive and invasive malignant melanoma in Western Australia. Int J Cancer 1980; 25: 317-323. (Pubitemid 10134236)
45. Chang YM, Barrett JH, Bishop DT, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 2009; 38: 814-830.
46. Moan J, Porojnicu AC, Dahlback A,. Epidemiology of cutaneous malignant melanoma. In, Ringborg U, Brandberg Y, Breitbart EW, et al., eds. Skin Cancer Prevention. Informa Healthcare, New York, 2007: 179-201.
47. Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005; 97: 195-199. (Pubitemid 40277369)
48. Lee EY, Williamson R, Watt P, et al. Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis. Int J Cancer 2006; 119: 636-642. (Pubitemid 43955718)
49. Linos E, Swetter SM, Cockburn MG, et al. Increasing burden of melanoma in the United States. J Invest Dermatol 2009; 129: 1666-1674.
50. Lee JA,. Declining effect of latitude on melanoma mortality rates in the United States. A preliminary study. Am J Epidemiol 1997; 146: 413-417.
51. Goodman KJ, Bible ML, London S, et al. Proportional melanoma incidence and occupation among white males in Los Angeles County (California, United States). Cancer Causes Control 1995; 6: 451-459.
52. Vollmer RT,. Solar elastosis in cutaneous melanoma. Am J Clin Pathol 2007; 128: 260-264. (Pubitemid 47262624)
53. Rigel DS,. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol 2008; 58: S129-S132. (Pubitemid 351506511)
54. Randerson-Moor JA, Taylor JC, Elliott F, et al. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 2009; 45: 3271-3281.
55. Asgari MM, Maruti SS, Kushi LH, et al. A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol 2009; 129: 1675-1680.
56. Rosso R, Kim N, Kirsner RS,. Vitamin D intake and melanoma risk. J Invest Dermatol 2009; 129: 1598.
57. Reichrath J, Nurnberg B,. Cutaneous vitamin D synthesis versus skin cancer development: The Janus faces of solar UV-radiation. Dermatoendocrinol 2009; 1: 253-261.
58. Nurnberg B, Graber S, Gartner B, et al. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res 2009; 29: 3669-3674.
59. Newton-Bishop JA, Beswick S, Randerson-Moor J, et al. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 2009; 27: 5439-5444.
60. Stevens NG, Liff JM, Weiss NS,. Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 1990; 45: 691-693. (Pubitemid 20146131)
61. Tsai T, Vu C, Henson DE,. Cutaneous, ocular and visceral melanoma in African Americans and Caucasians. Melanoma Res 2005; 15: 213-217. (Pubitemid 40839471)
62. Hu DN, Yu GP, McCormick SA,. Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas. Melanoma Res 2010; 20: 153-158.
63. Gloster HM Jr, Neal K,. Skin cancer in skin of color. J Am Acad Dermatol 2006; 55: 741-760. (Pubitemid 44556818)
64. Bradford PT, Goldstein AM, McMaster ML, et al. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol 2009; 145: 427-434.
65. Forman SB, Ferringer TC, Peckham SJ, et al. Is superficial spreading melanoma still the most common form of malignant melanoma? J Am Acad Dermatol 2008; 58: 1013-1020. (Pubitemid 351657607)
66. Phan A, Touzet S, Dalle S, et al. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol 2006; 155: 561-569. (Pubitemid 44215487)
67. Nagore E, Pereda C, Botella-Estrada R, et al. Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility. Cancer Causes Control 2009; 20: 115-119.
68. Albreski D, Sloan SB,. Melanoma of the feet: misdiagnosed and misunderstood. Clin Dermatol 2009; 27: 556-563.
69. Rolon PA, Kramarova E, Rolon HI, et al. Plantar melanoma: a case-control study in Paraguay. Cancer Causes Control 1997; 8: 850-856. (Pubitemid 27485460)
70. Godshalk SE, Paranjape T, Nallur S, et al. A variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma. Oncogene 2011; 30: 1542-1550.
71. Monsel G, Ortonne N, Bagot M, et al. c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes. Oncogene 2010; 29: 227-236.